Why BGPT?
logo

Traceable Claims in Bioinformatics

See what computational analyses actually reported, with provenance for every claim.Know what the science actually supports before you trust the answer.

Press Enter ↡ to search claims


     Long Response



    NRF2 vs BACH1 ChIP Comparison for Lung Tumor Samples β€” Graphs Blocked by Missing Raw ChIP Data

    You asked to create graphs comparing NRF2 and BACH1 ChIP across lung tumor samples. However, the provided β€œresearch data” contains no ChIP-seq/ChIP-qPCR measurements (no peak lists, signal tracks, read counts, bin-level matrices, or locus-level enrichment values) for NRF2/BACH1 in lung tumors. Without those raw numbers, I can’t truthfully render Plotly figures (and I will not fabricate or simulate ChIP signal).

    What I need to produce the requested Plotly graphs (raw inputs)

    • Sample metadata: sample IDs, tissue (lung tumor vs normal if available), cohort/batch, replicate mapping.
    • NRF2 ChIP data: either (a) peak-level tables (peak ID, chromosome, start/end, normalized score, FDR), or (b) a signal matrix (sample Γ— region bins) or bigWig-derived values.
    • BACH1 ChIP data: same structure as NRF2 so regions are comparable.
    • Common region definition strategy (choose one):
      • Union peaks (NRF2 βˆͺ BACH1) with per-sample signal extracted into one matrix.
      • Intersection peaks (NRF2 ∩ BACH1) only.
      • A fixed promoter/enhancer set (e.g., NRF2/BACH1 motif regions) with extracted ChIP signal.
    • Normalization definition: e.g., counts-per-million, RPKM, or normalized signal already computed upstream (I need to know which you used).

    If you upload peak tables / count matrices / bigWig-derived matrices, I can generate the full set of graphs you likely want (heatmaps, paired scatter plots, differential enrichment, and co-occupancy).

    Graph set (ready-to-render once raw numbers are provided)

    1. Per-sample NRF2 vs BACH1 scatter: x = NRF2 enrichment, y = BACH1 enrichment (color = tumor subtype/batch if provided).
    2. Co-occupancy quadrants: proportion of regions with (NRF2-high/BACH1-high), (NRF2-high/BACH1-low), etc.
    3. Region-level heatmap: rows = top variable regions (ranked by variance across samples), columns = samples; annotation tracks for NRF2 vs BACH1 high/low.
    4. Ξ” enrichment bar plot: for matched regions, plot Ξ” = NRF2 βˆ’ BACH1 summary statistics across samples (paired if you have matched replicates).
    5. Ranking plot: list of top NRF2-specific regions and top BACH1-specific regions (based on effect size or differential score).
    6. Optional locus profile plot: if you provide a few genomic loci of interest (chr:start-end), Plotly line plots per factor across samples.

    Critical check: the provided β€œresearch data” doesn’t include NRF2/BACH1 ChIP measurements

    The research excerpts you provided focus on other biological topics (e.g., Treg-driven ECM remodeling in breast cancer mouse models, and lung cancer epigenetic or transcriptional mechanisms unrelated to NRF2/BACH1 ChIP signal in lung tumors). None of it contains NRF2/BACH1 ChIP tables, peaks, or signal matrices for lung tumor samplesβ€”so I can’t construct data-faithful comparisons.

    Upload format suggestion (so graphs can be produced without assumptions)

    Upload a single wide matrix CSV with columns like: region_id, factor (NRF2/BACH1), sample_id, normalized_signal (or separate matrices per factor with identical region_id ordering). With that, I can immediately generate the Plotly figures.



    Feedback:    

    Updated: April 11, 2026

     Top Data Sources ExportMCP



     Analysis Wizard



    It will compute a shared-region enrichment matrix from uploaded NRF2/BACH1 ChIP tables, derive NRF2–BACH1 effect sizes, rank factor-specific regions, and output Plotly-ready summary tables for lung tumor samples.



     Science Art


    Create Graphs: Design NRF2 BACH1 ChIP Comparison for Lung Tumor Samples Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT